Healio (8/26, Schaffer) reports, “Melatonin may be a safe sleep aid for people with metabolic diseases and for healthy adults, and data suggest a beneficial glucose effect,” researchers concluded in a “systematic review and meta-analysis” that “assessed the effect of at least two weeks of daily treatment with melatonin on fasting glucose, insulin, insulin sensitivity and HbA1c levels across 11 randomized, placebo-controlled studies (n = 603).” The findings were published online in Clinical Endocrinology.
Related Links:
— “Melatonin safe sleep aid for adults with metabolic diseases “Regina Schaffer, Healio, August 26, 2021